Mission Wealth Management LP Sells 195 Shares of Centene Co. (NYSE:CNC)

Mission Wealth Management LP cut its stake in Centene Co. (NYSE:CNC) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,426 shares of the company’s stock after selling 195 shares during the period. Mission Wealth Management LP’s holdings in Centene were worth $510,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Capital Advisors Ltd. LLC raised its stake in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after buying an additional 177 shares during the last quarter. SRS Capital Advisors Inc. raised its stake in shares of Centene by 73.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after buying an additional 267 shares during the last quarter. Riverview Trust Co raised its stake in shares of Centene by 172.7% during the fourth quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after buying an additional 480 shares during the last quarter. Private Trust Co. NA raised its stake in shares of Centene by 75.3% during the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock worth $58,000 after buying an additional 332 shares during the last quarter. Finally, True Wealth Design LLC bought a new stake in shares of Centene during the third quarter worth approximately $66,000. 93.63% of the stock is owned by institutional investors.

Centene Stock Up 2.1 %

Centene stock opened at $59.09 on Thursday. The stock has a market capitalization of $29.31 billion, a PE ratio of 9.47, a price-to-earnings-growth ratio of 0.80 and a beta of 0.45. Centene Co. has a twelve month low of $55.03 and a twelve month high of $80.59. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The company has a 50 day moving average of $60.86 and a 200-day moving average of $64.78.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a net margin of 2.03% and a return on equity of 13.85%. The business had revenue of $40.81 billion during the quarter, compared to analysts’ expectations of $38.78 billion. During the same quarter in the prior year, the company posted $0.45 earnings per share. The firm’s revenue was up 3.4% on a year-over-year basis. On average, equities research analysts anticipate that Centene Co. will post 6.86 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director H James Dallas purchased 1,693 shares of the company’s stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of $59.01 per share, with a total value of $99,903.93. Following the completion of the transaction, the director now owns 1,693 shares of the company’s stock, valued at $99,903.93. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Theodore R. Samuels II purchased 5,000 shares of the company’s stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of $58.86 per share, for a total transaction of $294,300.00. Following the completion of the transaction, the director now directly owns 23,000 shares of the company’s stock, valued at approximately $1,353,780. This represents a 27.78 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 23,693 shares of company stock worth $1,409,954. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Truist Financial dropped their price target on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. Robert W. Baird boosted their price objective on shares of Centene from $66.00 to $71.00 in a report on Tuesday, February 4th. Oppenheimer decreased their price objective on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, December 13th. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Finally, Argus cut shares of Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, Centene has an average rating of “Moderate Buy” and an average target price of $79.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.